Cutaneous vasculitis after COVID‐19 vaccination in a 41‐year‐old male

Leukocytoclastic vasculitis could be a possible adverse event of different SARS‐CoV‐2 vaccines. Clinicians and manufacturers should be aware of this adverse event for appropriate diagnosis and treatment.

Detalles Bibliográficos
Autores principales: Pournazari, Mehran, Assar, Shirin, Farsad, Faraneh, Mohamadzadeh, Dena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Images
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122690/
https://www.ncbi.nlm.nih.gov/pubmed/37155418
http://dx.doi.org/10.1002/ccr3.7238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122690/
https://www.ncbi.nlm.nih.gov/pubmed/37155418
http://dx.doi.org/10.1002/ccr3.7238

Ejemplares similares